 Dr Agarwals Health Care Ltd reports Rs. 29.69 crores consolidated PAT in Q2 FY2026
Dr Agarwals Health Care Ltd reports Rs. 29.69 crores consolidated PAT in Q2 FY2026 IIRM Holdings India Ltd consolidated Q2FY26 profit at Rs. 5.24 crores
IIRM Holdings India Ltd consolidated Q2FY26 profit at Rs. 5.24 crores Automotive Axles Ltd Q2 FY2026 net profit at Rs. 35.95 crores
Automotive Axles Ltd Q2 FY2026 net profit at Rs. 35.95 crores Lodha Developers Ltd consolidated net profit for Q2FY26 increases to Rs. 788.7 crores
Lodha Developers Ltd consolidated net profit for Q2FY26 increases to Rs. 788.7 crores Pidilite Industries Ltd Q2 FY26 consolidated net profit at Rs. 579.23 crores
Pidilite Industries Ltd Q2 FY26 consolidated net profit at Rs. 579.23 crores 
              Coromandel International's (CIL) Q1FY11 net sales remained flat at Rs15.5bn (-2.5% YoY). However, implementation of NBS policy and benefits from working capital management resulted in OPM expanding by 2.6x to 12%. Consequently net profit surged by 132.9% YoY to Rs1.2bn against our estimate of Rs950mn.
Outlook: We believe that fertiliser sector is going through a structural change where we will see lots of fresh investment driven by favorable policy environment in coming years, against lackluster last decade and hence we do not see any negativity arising out of govt intervention at regular intervals.
VALUATIONS AND RECOMMENDATION
We have increased our EPS estimate for FY11 and FY12 by 13% and 16% respectively on the back of higher volumes and better margins. At the CMP of Rs508, CIL trades at FY11 and FY12 P/E of 12.8x and 10.5x and EV/EBITDA of 8.4x and 6.6x respectively. We maintain our 'BUY' recommendation, with an increased target price of Rs581 (12x FY12E EPS), on the back of higher multiple post-NBS, a premium to Urea players.